Ferring Pharmaceuticals launches Nocdurna in US to treat nocturia
Ferring Pharmaceuticals has announced the launch of Nocdurna (desmopressin acetate) in the United States, marking a significant advancement in the treatment of nocturia caused by nocturnal polyuria. This new medication is designed for adults who experience the disruptive need to urinate at least twice during the night. Nocdurna will be available by prescription in pharmacies […]